Global Midazolam Injection Market Research Report 2024

Publication ID:

PB505247477

Publication Date:

June 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

This medication may also be used to help with anesthesia or to sedate people who need a tube or machine to help with breathing.听
The global Midazolam Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Midazolam Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Midazolam Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Midazolam Injection include Akorn, Athenex, Avet Pharmaceuticals, Fresenius Kabi, Hikma, Pfizer, Sun Pharmaceutical, Sandoz and Hameln Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Midazolam Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Midazolam Injection.
Report Scope
The Midazolam Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Midazolam Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Midazolam Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Akorn
Athenex
Avet Pharmaceuticals
Fresenius Kabi
Hikma
Pfizer
Sun Pharmaceutical
Sandoz
Hameln Pharma
Yichang Humanwell Pharmaceutical
Jiangsu Nhwa Group
Segment by Type
1mg/ml
5mg/ml
Segment by Application
Hospital
Clinics
Recovery Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Midazolam Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Midazolam Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Midazolam Injection Market Overview
1.1 Product Overview and Scope of Midazolam Injection
1.2 Midazolam Injection Segment by Type
1.2.1 Global Midazolam Injection Market Value Comparison by Type (2024-2030)
1.2.2 1mg/ml
1.2.3 5mg/ml
1.3 Midazolam Injection Segment by Application
1.3.1 Global Midazolam Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Global Midazolam Injection Market Size Estimates and Forecasts
1.4.1 Global Midazolam Injection Revenue 2019-2030
1.4.2 Global Midazolam Injection Sales 2019-2030
1.4.3 Global Midazolam Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Midazolam Injection Market Competition by Manufacturers
2.1 Global Midazolam Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Midazolam Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Midazolam Injection Average Price by Manufacturers (2019-2024)
2.4 Global Midazolam Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Midazolam Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Midazolam Injection, Product Type & Application
2.7 Midazolam Injection Market Competitive Situation and Trends
2.7.1 Midazolam Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Midazolam Injection Players Market Share by Revenue
2.7.3 Global Midazolam Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Midazolam Injection Retrospective Market Scenario by Region
3.1 Global Midazolam Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Midazolam Injection Global Midazolam Injection Sales by Region: 2019-2030
3.2.1 Global Midazolam Injection Sales by Region: 2019-2024
3.2.2 Global Midazolam Injection Sales by Region: 2025-2030
3.3 Global Midazolam Injection Global Midazolam Injection Revenue by Region: 2019-2030
3.3.1 Global Midazolam Injection Revenue by Region: 2019-2024
3.3.2 Global Midazolam Injection Revenue by Region: 2025-2030
3.4 North America Midazolam Injection Market Facts & Figures by Country
3.4.1 North America Midazolam Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Midazolam Injection Sales by Country (2019-2030)
3.4.3 North America Midazolam Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Midazolam Injection Market Facts & Figures by Country
3.5.1 Europe Midazolam Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Midazolam Injection Sales by Country (2019-2030)
3.5.3 Europe Midazolam Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Midazolam Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Midazolam Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Midazolam Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Midazolam Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Midazolam Injection Market Facts & Figures by Country
3.7.1 Latin America Midazolam Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Midazolam Injection Sales by Country (2019-2030)
3.7.3 Latin America Midazolam Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Midazolam Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Midazolam Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Midazolam Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Midazolam Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Midazolam Injection Sales by Type (2019-2030)
4.1.1 Global Midazolam Injection Sales by Type (2019-2024)
4.1.2 Global Midazolam Injection Sales by Type (2025-2030)
4.1.3 Global Midazolam Injection Sales Market Share by Type (2019-2030)
4.2 Global Midazolam Injection Revenue by Type (2019-2030)
4.2.1 Global Midazolam Injection Revenue by Type (2019-2024)
4.2.2 Global Midazolam Injection Revenue by Type (2025-2030)
4.2.3 Global Midazolam Injection Revenue Market Share by Type (2019-2030)
4.3 Global Midazolam Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Midazolam Injection Sales by Application (2019-2030)
5.1.1 Global Midazolam Injection Sales by Application (2019-2024)
5.1.2 Global Midazolam Injection Sales by Application (2025-2030)
5.1.3 Global Midazolam Injection Sales Market Share by Application (2019-2030)
5.2 Global Midazolam Injection Revenue by Application (2019-2030)
5.2.1 Global Midazolam Injection Revenue by Application (2019-2024)
5.2.2 Global Midazolam Injection Revenue by Application (2025-2030)
5.2.3 Global Midazolam Injection Revenue Market Share by Application (2019-2030)
5.3 Global Midazolam Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Akorn
6.1.1 Akorn Corporation Information
6.1.2 Akorn Description and Business Overview
6.1.3 Akorn Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Akorn Midazolam Injection Product Portfolio
6.1.5 Akorn Recent Developments/Updates
6.2 Athenex
6.2.1 Athenex Corporation Information
6.2.2 Athenex Description and Business Overview
6.2.3 Athenex Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Athenex Midazolam Injection Product Portfolio
6.2.5 Athenex Recent Developments/Updates
6.3 Avet Pharmaceuticals
6.3.1 Avet Pharmaceuticals Corporation Information
6.3.2 Avet Pharmaceuticals Description and Business Overview
6.3.3 Avet Pharmaceuticals Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Avet Pharmaceuticals Midazolam Injection Product Portfolio
6.3.5 Avet Pharmaceuticals Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Kabi Midazolam Injection Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Hikma
6.5.1 Hikma Corporation Information
6.5.2 Hikma Description and Business Overview
6.5.3 Hikma Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hikma Midazolam Injection Product Portfolio
6.5.5 Hikma Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Midazolam Injection Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Midazolam Injection Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 Sandoz
6.8.1 Sandoz Corporation Information
6.8.2 Sandoz Description and Business Overview
6.8.3 Sandoz Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sandoz Midazolam Injection Product Portfolio
6.8.5 Sandoz Recent Developments/Updates
6.9 Hameln Pharma
6.9.1 Hameln Pharma Corporation Information
6.9.2 Hameln Pharma Description and Business Overview
6.9.3 Hameln Pharma Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hameln Pharma Midazolam Injection Product Portfolio
6.9.5 Hameln Pharma Recent Developments/Updates
6.10 Yichang Humanwell Pharmaceutical
6.10.1 Yichang Humanwell Pharmaceutical Corporation Information
6.10.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.10.3 Yichang Humanwell Pharmaceutical Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yichang Humanwell Pharmaceutical Midazolam Injection Product Portfolio
6.10.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
6.11 Jiangsu Nhwa Group
6.11.1 Jiangsu Nhwa Group Corporation Information
6.11.2 Jiangsu Nhwa Group Midazolam Injection Description and Business Overview
6.11.3 Jiangsu Nhwa Group Midazolam Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jiangsu Nhwa Group Midazolam Injection Product Portfolio
6.11.5 Jiangsu Nhwa Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Midazolam Injection Industry Chain Analysis
7.2 Midazolam Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Midazolam Injection Production Mode & Process
7.4 Midazolam Injection Sales and Marketing
7.4.1 Midazolam Injection Sales Channels
7.4.2 Midazolam Injection Distributors
7.5 Midazolam Injection Customers
8 Midazolam Injection Market Dynamics
8.1 Midazolam Injection Industry Trends
8.2 Midazolam Injection Market Drivers
8.3 Midazolam Injection Market Challenges
8.4 Midazolam Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Akorn
Athenex
Avet Pharmaceuticals
Fresenius Kabi
Hikma
Pfizer
Sun Pharmaceutical
Sandoz
Hameln Pharma
Yichang Humanwell Pharmaceutical
Jiangsu Nhwa Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂